Anticuerpos de dominio simple vhh contra el virus sars-cov-2

La invención proporciona un conjunto de nuevos anticuerpos de dominio simple VHH contra SARS-CoV-2 (SEQ ID N°1-6) y su uso para detectar y neutralizar el virus de tipo silvestre. One-step rapid gradient method for rapid generation of nanoantibodies (HHV) against any antigen. Where the method compris...

Full description

Saved in:
Bibliographic Details
Main Authors Teresa Pinto, Alexei Cuevas, Ananda Muller, Alejandro Rojas, Constanza Salinas, Natalia López, Benjamín Uberti, Ronald Jara, Zaray Miranda, Guillermo Valenzuela, Johanna Himelreichs, Yorka Cheuquemilla
Format Patent
LanguageSpanish
Published 07.07.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:La invención proporciona un conjunto de nuevos anticuerpos de dominio simple VHH contra SARS-CoV-2 (SEQ ID N°1-6) y su uso para detectar y neutralizar el virus de tipo silvestre. One-step rapid gradient method for rapid generation of nanoantibodies (HHV) against any antigen. Where the method comprises the separation of nanoantibodies against a specific antigen from a nanoantibody expression library through the following steps:(a) binding the antigen of interest to beads made of protein-binding polymers(b) incubating the microorganisms of the expression library with the pearls of stage (a),(c) placing the beads of step (b) in a tube with an inert medium with a density greater than or equal to 1 g/mL and centrifuge for 45 s to 2 minutes at a rate between 150 and 250 g;d) discarding the upper fraction and supernatant with the free microorganisms, and obtain the beads with the linked microorganisms, which correspond to those that express HHV that recognizes the antigen.
Bibliography:Application Number: CL20220003173